Publication | Closed Access
Clinical trial of valproic acid and all‐trans retinoic acid in patients with poor‐risk acute myeloid leukemia
185
Citations
20
References
2005
Year
Treatment with VPA/ATRA results in transient disease control in a subset of patients with AML that has evolved from a myeloproliferative disorder but not in patients with a primary or MDS-related AML.
| Year | Citations | |
|---|---|---|
Page 1
Page 1